Comparison of genetic and health risk factors for mild cognitive impairment and Alzheimer's disease between Hispanic and non‐Hispanic white participants

INTRODUCTION The influence of apolipoprotein E (APOE) genotype on mild cognitive impairment (MCI) and Alzheimer's disease (AD) is well studied in the non-Hispanic white (NHW) population but not in the Hispanic population. Additionally, health risk factors such as hypertension, stroke, and depression may also differ between the two populations. METHODS We combined three data sets (National Alzheimer's Coordinating Center [NACC], Alzheimer's Disease Neuroimaging Initiative [ADNI], Health and Aging Brain Study: Health Disparities [HABS-HD]) and compared risk factors for MCI and AD between Hispanic and NHW participants, with a total of 24,268 participants (11.1% Hispanic). RESULTS APOEε4 was associated with fewer all-cause MCI cases in Hispanic participants (Hispanic odds ratio [OR]: 1.114; NHW OR: 1.453), and APOEε2 (Hispanic OR: 1.224; NHW OR: 0.592) and depression (Hispanic OR: 2.817; NHW OR: 1.847) were associated with more AD cases in Hispanic participants. DISCUSSION APOEε2 may not be protective for AD in Hispanic participants and Hispanic participants with depression may face a higher risk for AD. HIGHLIGHTS GAAIN allows for discovery of data sets to use in secondary analyses. APOEε2 was not protective for AD in Hispanic participants. APOEε4 was associated with fewer MCI cases in Hispanic participants. Depression was associated with more AD cases in Hispanic participants.

[1]  J. Weiss,et al.  Apolipoprotein E (APOE) genotype, dementia, and memory performance among Caribbean Hispanic versus US populations , 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[2]  A. Toga,et al.  The Link between APOE4 Presence and Neuropsychological Test Performance among Mexican Americans and Non-Hispanic Whites of the Multiethnic Health & Aging Brain Study – Health Disparities Cohort , 2022, Dementia and Geriatric Cognitive Disorders.

[3]  L. Tan,et al.  The Proportion of APOE4 Carriers Among Non-Demented Individuals: A Pooled Analysis of 389,000 Community-Dwellers. , 2021, Journal of Alzheimer's disease : JAD.

[4]  A. Toga,et al.  The Health & Aging Brain among Latino Elders (HABLE) study methods and participant characteristics , 2021, Alzheimer's & dementia.

[5]  P. Sachdev,et al.  Hypertension and Alzheimer's disease: is the picture any clearer? , 2020, Current opinion in psychiatry.

[6]  M. Fornage,et al.  APOE alleles’ association with cognitive function differs across Hispanic/Latino groups and genetic ancestry in the study of Latinos‐investigation of neurocognitive aging (HCHS/SOL) , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[7]  A. Espay,et al.  Ethnic Differences Between Hispanics and Non-Hispanic Whites in Neuropsychiatric Symptoms Predict Conversion to Mild Cognitive Impairment , 2020, Journal of geriatric psychiatry and neurology.

[8]  A. Yashin,et al.  APOE region molecular signatures of Alzheimer's disease across races/ethnicities , 2019, Neurobiology of Aging.

[9]  M. Mendez,et al.  Bilingualism Delays Expression of Alzheimer’s Clinical Syndrome , 2020, Dementia and Geriatric Cognitive Disorders.

[10]  L. Ryan,et al.  The impact of cardiovascular risk factors on cognition in Hispanics and non-Hispanic whites , 2019, Learning & memory.

[11]  L. D. de Souza,et al.  Alzheimer’s disease: risk factors and potentially protective measures , 2019, Journal of Biomedical Science.

[12]  Kevin S. Hanson,et al.  Effect of age, ethnicity, sex, cognitive status and APOE genotype on amyloid load and the threshold for amyloid positivity , 2019, NeuroImage: Clinical.

[13]  Silvia Maioli,et al.  Alterations in cholesterol metabolism as a risk factor for developing Alzheimer’s disease: Potential novel targets for treatment , 2019, The Journal of Steroid Biochemistry and Molecular Biology.

[14]  S. O'Bryant,et al.  Depression, inflammation, and memory loss among Mexican Americans: analysis of the HABLE cohort , 2017, International Psychogeriatrics.

[15]  Irving E. Vega,et al.  Alzheimer's Disease in the Latino Community: Intersection of Genetics and Social Determinants of Health. , 2017, Journal of Alzheimer's disease : JAD.

[16]  Arthur W. Toga,et al.  Sharing data in the global alzheimer's association interactive network , 2016, NeuroImage.

[17]  A. Toga,et al.  The Global Alzheimer's Association Interactive Network , 2016, Alzheimer's & Dementia.

[18]  P. Wolf,et al.  APOE and mild cognitive impairment: the Framingham Heart Study. , 2015, Age and ageing.

[19]  L. Tan,et al.  Association between stroke and Alzheimer's disease: systematic review and meta-analysis. , 2015, Journal of Alzheimer's disease : JAD.

[20]  Huaxi Xu,et al.  Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy , 2013, Nature Reviews Neurology.

[21]  Mark E. Schmidt,et al.  The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans , 2010, Alzheimer's & Dementia.

[22]  Joylee Wu,et al.  The National Alzheimer's Coordinating Center (NACC) Database: The Uniform Data Set , 2007, Alzheimer disease and associated disorders.

[23]  David Loewenstein,et al.  Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. , 2006, Archives of general psychiatry.

[24]  Douglas G Altman,et al.  Interaction revisited: the difference between two estimates , 2003, BMJ : British Medical Journal.

[25]  R. Ownby,et al.  Apolipoprotein E Polymorphism and Cognitive Impairment in A Bi-Ethnic Community-Dwelling Elderly Sample , 2002, Alzheimer disease and associated disorders.

[26]  K. Marder,et al.  The APOE- (cid:101) 4 Allele and the Risk of Alzheimer Disease Among African Americans, Whites, and Hispanics , 2001 .

[27]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .